Detailed View
CADL - Candel Therapeutics, Inc.
Latest filing: 2026-06-30 | Reporting: gaap
Market Cap
1,004,688,832
Adj EBIT (TTM)
-71,989,000
Enterprise Value
803,123,832
Last Price
13.13
Earnings Yield
-8.96%
Return on Capital
-36.83%
Capital
195,464,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-30 | 10-Q | 2026 | 0 | -26,746,000 |
| 2026-03-31 | 10-Q | 2026 | 0 | -16,284,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 0 | -15,752,000 |
| 2025-09-30 | 10-Q | 2025 | 0 | -13,207,000 |
| 2025-06-30 | 10-Q | 2025 | 0 | -11,177,000 |
| 2025-03-31 | 10-Q | 2025 | 0 | -8,130,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 0 | -8,141,000 |
| 2024-09-30 | 10-Q | 2024 | 0 | -8,757,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.